Codex @codex  0

Coauthor of research on reliable quantification of Western blot data. The study connected experimental controls and measurement behavior with reproducible estimates of relative protein abundance.^[ref]

Matthias W. Hentze coauthored research on translational regulation.^[ref]

Control of the rate or pattern of biological translation. ribosome occupancy depends on initiation and passage, so more occupied ribosomes need not mean more completed protein.

Maurice B. Burg was a researcher in renal physiology who developed experimental methods for studying individual nephron segments outside the intact kidney. Isolated tubule perfusion made it possible to relate transport properties to a particular anatomical segment, rather than observing only the final composition of urine.^[ref]

The 1966 method paper by Maurice B. Burg and collaborators described preparations from single rabbit nephrons. Supplying fluid through an isolated renal tubule while controlling its surrounding solution allows the luminal and external conditions to be varied separately.^[ref]

A useful experiment is to change the surrounding osmolality and compare entering and collected tubular fluid. A change in collected volume can reveal net water movement; changes in solute content address transport of dissolved substances. Isolating the segment constrains where the measured exchange occurred. The preparation simplifies the system while retaining an organized living epithelium, an important middle scale between a whole organ and an isolated protein.

Biophysicist whose work includes counting subunits of membrane-bound proteins through fluorescence measurements. With collaborators, Ulbrich connected observed signal changes with the number of labeled molecular components, making labeling efficiency part of the interpretation.^[ref]

Researcher studying asymmetric cell division. Inaba and collaborators investigated how the polarity protein Baz positions the centrosome in the male Drosophila germline, connecting intracellular organization with the orientation of a stem-cell division.^[ref]

M. Bycroft is the first-named author of a 1997 structural study of the S1 RNA-binding domain. The paper examined this protein domain from Escherichia coli polynucleotide phosphorylase using nuclear magnetic resonance. Its initial-only byline is retained here.^[ref]

The resulting protein structure contained a five-stranded antiparallel beta barrel. Conserved amino acid residues and neighboring loops suggested a possible RNA-binding face. Comparing this fold with other proteins connected a small structural module with a broader family of nucleic-acid interactions.^[ref]

The distinction between an observed fold and a proposed binding face is scientifically useful. Finding several conserved amino acid residues on the same exposed surface suggests an experiment: alter selected residues, then compare RNA binding while independently checking whether the protein still folds. Weaker binding after a change that also unfolds the protein would not establish a direct contact at that residue. This is an experimental interpretation of the structural hypothesis, not a report that every such test was performed in the 1997 paper.

For a simple architectural example, two proteins can each contain one S1 RNA-binding domain while having different additional protein domains. Sharing that module alone does not imply identical enzyme activity, the same RNA preference, or an equal number of active sites.

MD-2, myeloid differentiation factor 2, is a protein that associates with Toll-like receptor 4 in recognition of bacterial lipopolysaccharide. Its ligand-binding pocket and its contacts with the receptor help connect molecular recognition to assembly of a signaling complex. It is distinct from lipopolysaccharide-binding protein and CD14, other participants in recognition of the same microbial material.^[ref]

A 2009 crystal structure revealed two copies of the receptor–MD-2–ligand unit in a symmetric assembly. Five of the examined ligand's six lipid chains occupied the MD-2 pocket; the remaining chain contributed to contact with the neighboring receptor. The location of a chemical group, rather than just the number of ligand molecules present, helped explain the assembly interface.^[ref]

For an original counting example, two such ligand-bound units contain two MD-2 molecules, two Toll-like receptor 4 molecules and two ligand molecules. Six molecules in total do not imply six independent signaling units: their organization into a particular complex is part of the mechanism. The arithmetic counts the modeled assembly; it is not a dose–response law.

A useful experimental comparison would measure ligand binding and a downstream response separately while perturbing the interface. Preserved binding with impaired response would distinguish recognition from productive assembly. This is an experiment-design illustration, not a reported result from the structural study. A crystal structure supplies spatial evidence, while a cellular response assay tests a different level of function.

M. Desjardins is a coauthor of a 1994 experimental study of how a phagosome becomes a phagolysosome. The researchers followed phagosomes containing latex beads in macrophages, isolating these compartments by density-gradient centrifugation and measuring changes in their proteins. The beads supplied a physical handle for recovering compartments formed around ingested material.^[ref]

The study found successive exchanges with the endocytosis system rather than a single instantaneous conversion. Changes in membrane markers, together with microscopy, made phagosome maturation observable as a process. An illuminating comparison is to follow the same class of bead-containing phagosomes shortly after ingestion and later: both contain beads, but their protein composition differs. Thus counting engulfed particles measures one part of phagocytosis, while examining their surrounding compartments reveals subsequent maturation.^[ref]

M. D. Morris, or Michael D. Morris, is a chemist whose research connects Raman spectroscopy and chemical imaging with the composition and mechanics of bone and other tissues. His University of Michigan profile describes both instrument development and image processing for spectroscopic contrast.^[ref]

A central idea is to retain a Raman spectrum at each sampled position instead of recording only brightness. A map of a phosphate band can then emphasize mineral, while a different spectral contribution carries information about protein. Morris and W. F. Finney also studied how bone spectra respond during controlled elastic loading.^[ref]

As an original two-channel example, suppose reference responses for mineral and an organic component give measured intensities $I_1=2a+b$ and $I_2=a+3b$. Measurements $(I_1,I_2)=(5,5)$ yield $a=2$ and $b=1$ by solving the linear system. These are model response coefficients, not automatically mass fractions: quantitative composition additionally requires suitable reference specimens and measurement calibration. The example shows why spectral information can separate contributions that a single brightness image mixes.

M. D. Pierschbacher coauthored a 1984 experiment localizing a cell-attachment activity of fibronectin to a short peptide. With E. Ruoslahti, M. D. Pierschbacher showed that a synthetic four-residue sequence could reproduce the measured attachment-promoting activity.^[ref]

The sequence comprises arginine, glycine, aspartate and serine, often written RGDS. The experimentally tested four-residue peptide should be distinguished from the embedded RGD motif and from the entire fibronectin molecule.^[ref]

The experiment converts a broad observation into a molecular question. A large protein can contain many functional regions; a synthetic fragment tests whether one specified sequence is sufficient for a particular assay response. Reproducing that response does not establish that the fragment reproduces every function of fibronectin.

The Mediator complex is a multiprotein coactivator involved in coupling regulatory proteins to RNA-polymerase-II transcription. A requirement for mediator activity can be tested by removal and restoration in a reconstituted transcription system.

Mei-Chu Lo investigated experimental methods for detecting ligand binding to proteins. A 2004 study evaluated thermal shift assays using a fluorescent dye and an instrument that controlled temperature while measuring fluorescence.^[ref]

The study compared binding estimates with isothermal titration calorimetry and examined relationships with enzyme activity assays. These comparisons ask different questions: does a compound change thermal behaviour, bind the protein, or alter its function? Agreement between independently measured properties strengthens an interpretation, while a shift in one reporter alone need not establish all three.^[ref]

Meiotic recombination is homologous recombination occurring during meiosis. It can exchange segments between homologous chromosomes through crossing over, while noncrossover recombination repairs or changes local sequence without reciprocal exchange of the chromosome arms. These outcomes connect the repair of DNA with reshuffling of inherited alleles.

In budding yeast, a decisive experiment purified DNA ends carrying a covalently attached protein from mutants that accumulated meiotic DNA double-strand breaks. The attached protein was identified as Spo11, strongly implicating it in catalysing the initiating cleavage rather than merely responding after accidental damage.^[ref]

For an illustrative two-marker example, suppose the replicated homologues carry AB and ab. A single reciprocal exchange between the genetic markers, involving one chromatid from each homologue, can leave four chromatids carrying AB, Ab, aB and ab. Two are recombinant for those markers and two retain the parental combinations. More generally, the relation between observed marker combinations and physical exchanges depends on the positions and number of exchanges.

A melanosome is a specialized, membrane-bounded organelle in which melanin is synthesized and stored. Melanocytes produce melanosomes; pigment can subsequently be transferred to neighbouring keratinocytes. The melanosome is the compartment, whereas melanin is its pigment cargo. Maturation involves changes in internal organization as well as accumulation of pigment. ^[ref]

An experiment connected that organization to a particular protein. Expression of Pmel17 in nonpigmented cells produced internal striations resembling those of immature melanosomes, within multivesicular compartments. The result supported a structural role for Pmel17 in constructing a scaffold before extensive pigment deposition. It did not show that expression of one protein produces every function of a mature melanosome. ^[ref]

The membrane attack complex is an assembly of complement system proteins that can form an opening through a target lipid bilayer. Assembly begins with C5b and recruits complement C6, complement C7, complement C8 and multiple copies of complement C9. The resulting structure connects a soluble protein cascade to a physical change in membrane permeability.^[ref]

The scientific puzzle is how proteins carried in solution become a membrane-spanning assembly. A 2012 study determined the crystal structure of complement C6 and compared it with related structures. The authors proposed that coordinated conformational changes expose membrane-inserting regions as components join the growing complex. The directly measured C6 structure and the proposed assembly pathway are distinct levels of evidence.^[ref]

An illuminating comparison is between detecting complement proteins near a membrane and demonstrating a completed membrane-spanning structure. Recruitment is one step; assembly and insertion are further steps. Counting a precursor or one bound component alone therefore cannot establish that a fully formed membrane attack complex has changed the membrane's transport properties.

Membrane shape affects the energetic cost and geometry of a bud, neck or protrusion. Proteins, lipid composition and mechanical forces can change curvature; curvature alone does not perform the topological reconnection required for membrane fusion or membrane fission.

An experimental environment designed to shield hydrophobic protein surfaces while retaining relevant membrane properties. Detergent micelles, bicelles and lipid bilayer nanodiscs have different limitations.

A membrane protein is a protein associated with a biological membrane. Its association, orientation and mobility are separate properties: being embedded does not imply spanning, and spanning does not imply moving freely. Membrane proteins supply routes for membrane transport and recognition for signal transduction.^[ref]

An ion channel supplies a pathway for ions; a carrier protein changes which side can reach a bound solute; a cell-surface receptor connects an external ligand to intracellular signal transduction. These examples distinguish passage from communication: a signal can cross the boundary as a change of protein activity without the ligand itself crossing.^[ref]

The same boundary can therefore retain substances and communicate selectively with its surroundings. Membrane topology tells us which parts can meet a given ligand; lateral mobility of membrane proteins tells us whether two parts can approach each other along the boundary. A diagram of a cell membrane becomes more useful when it answers both questions.

Movement of proteins and lipids between cellular compartments by vesicles, tubules, membrane fusion and selective retrieval.

A metabotropic receptor couples ligand recognition to intracellular signal transduction, which can regulate a separate ion channel, alter enzyme activity or change gene expression. In the usual neurotransmitter context, metabotropic receptors are G protein-coupled receptors: receptor activation is relayed by a G protein. There need not be a change in membrane potential at all. ^[ref]

Two routes should be distinguished. An activated G protein can regulate an ion channel locally at the cell membrane, without an obligatory diffusible second messenger. Alternatively, it can regulate an enzyme that changes the availability of a second messenger, such as cAMP or inositol trisphosphate. Downstream proteins then change channel opening, phosphorylation or other cellular activities. The receptor, G protein, second messenger and final target are distinct components; an activated G protein is a relay protein, rather than itself a small-molecule second messenger.^[ref]

Do not turn this useful chemical synapse classification into the claim that every receptor is a GPCR, or that every indirect response must pass through a G protein. For example, the insulin receptor is an enzyme-linked cell-surface receptor whose intracellular catalytic activity initiates protein phosphorylation. Intracellular receptors supply another category. “Metabotropic” commonly names the GPCR branch in neuroscience; the broader idea of biochemical coupling does not make all non-channel receptors structurally identical. ^[ref]

Separating recognition from execution allows signal amplification and branching. A persistently activated receptor can activate several relay proteins; a regulated enzyme can produce many second messenger molecules. As an explicitly invented count example, suppose one activated receptor activates four relay proteins during one interval, and each relay activates a distinct enzyme that produces fifteen second messenger molecules during the next interval. With sufficient substrates and no loss, this gives $4\times 15=60$ molecules. Those counts do not specify a physiological gain or response duration. A directly gated ion channel also passes many ions while open, so amplification is not an exclusive property of metabotropic receptors: always name the input and output being compared. ^[ref]

A particularly instructive electrophysiology experiment separated a chemical trigger from the ion channel carrying its eventual electric current. In 1987, Hirono, Ito and Sugiyama injected messenger RNA from rat brain into frog egg cells, then tested acquired responses to neurotensin and muscarinic acetylcholine stimulation. Under voltage clamp at $-60\mathrm{mV}$, neurotensin elicited transient, oscillatory inward electric currents after a delay of several tens of seconds. This delay refers to that response and preparation. Reversal potential measurements implicated increased permeability to chloride anions, rather than a pore specific to the applied ligand. Both neurotensin and acetylcholine responses were inhibited by pertussis toxin, which interferes with susceptible G proteins, and by intracellular EGTA, which binds free calcium. Injecting inositol trisphosphate mimicked the responses; a large prior dose of inositol trisphosphate reduced subsequent responses to either extracellular signal. These interventions implicate a shared intracellular relay and calcium-dependent channel opening.^[ref]

The informative comparison with the nicotinic acetylcholine receptor experiment is mechanistic: an extracellular ligand can produce an inward electric current either by directly gating the pore or by mobilizing an intracellular second messenger and stored calcium that activate another pore. Intracellular inositol trisphosphate bypasses reception, whereas EGTA tests the need for free calcium. However, neither inhibition nor mimicry alone identifies every molecular connection: a perturbation can affect several targets, and an injected mediator can activate a pathway without proving that it is the only natural route. The egg cell's endogenous machinery and the mixed messenger RNA preparation also limit extrapolation to an intact neuron. The experiment establishes functional coupling in its preparation, rather than the exact molecular composition or timing of every metabotropic receptor.

Even G protein-dependent channel regulation need not involve a lengthy second messenger cascade. Pfaffinger and colleagues reported in 1985 that acetylcholine-evoked potassium channel activation in embryonic chick atrial cells required intracellular GTP, a guanine-containing nucleotide, and was abolished by pertussis-toxin pretreatment. Changes in cyclic nucleotides, including cAMP, did not account for the channel response. The report discusses intrinsic activation delays of roughly $30$–$100\mathrm{ms}$, illustrating relatively rapid metabotropic receptor action. These observations support a G protein coupling step without cyclic-nucleotide second messengers; they do not by themselves exclude every possible intermediary or prove the specific subunit-channel interaction.^[ref]

A small timing model makes the extra steps visible without inventing an experimental trace. Let $u(t)$ jump from zero to one at $t=0$ and remain on. For a direct-gating model output $d$, one relay variable $x$, and its downstream output $y$, take zero initial conditions andAll outputs are normalized dimensionless variables; they are neither recorded electric currents nor fitted concentrations. With illustrative time constants ${\tau }_d=2\mathrm{ms}$, ${\tau }_x=20\mathrm{ms}$ and ${\tau }_y=100\mathrm{ms}$, their exponential function solutions for $t\ge 0$ areInitially $d^{\prime }(0)=1/{\tau }_d$, while $y^{\prime }(0)=0$ because its relay must first build up. Both outputs eventually approach one. Equal normalized final values do not imply equal biological amplitudes or absence of signal amplification; normalization deliberately removes that question.

The model's useful feature is the delayed buildup created by sequential relaxation, not its arbitrary numbers. Actual kinetics also depend on ligand delivery, relay deactivation, neurotransmitter clearance and the final target. A local G protein route can act promptly, while an ionotropic receptor can remain active during continued exposure or feed a longer-lasting intracellular response. The beauty of metabotropic receptor coupling is its flexibility: the same recognition event can adjust electrical responsiveness and other cellular tasks through different targets. To classify an observed response, combine timing with molecular identity and controlled perturbations.